MUMBAI Generic drugmaker Dr. Reddy's Laboratories Ltd (REDY.NS) is recalling about 58,656 bottles of the heartburn drug lansoprazole in the United States due to a microbial contamination, the U.S. Food and Drug Administration said.
It was classified as a "Class II" recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.
While product recalls are not uncommon, the FDA announcement comes amid a string of quality problems for Indian drug makers.
In a weekly report, the U.S. regulator also announced it was banning imports from Sun Pharmaceutical Industries (SUN.NS) Karkhadi manufacturing plant in Gujarat.
And just last week, the FDA disclosed that products made by Sun Pharma and Ranbaxy Laboratories (RANB.NS) were being recalled.
Dr. Reddy's voluntary recall of lansoprazole delayed release capsules, a generic version of Swiss drugmaker Novartis' NOVN.VX drug Prevacid 24 HR, began on January 3, 2014, the FDA said on its website.
A spokesman for Dr. Reddy's was not immediately available to comment.
(Reporting by Zeba Siddiqui; Editing by Edwina Gibbs)
India's growth pace likely slowed in April-June: Reuters Poll
BENGALURU India's economic growth likely lost some momentum in the April-June quarter on cutbacks in domestic and global demand, a Reuters poll showed.
Bharti Airtel cuts mobile data prices as new rival Jio looms
MUMBAI Bharti Airtel Ltd, India's top mobile phone carrier, cut prices of its mobile data services on a special plan on Monday, accelerating discounts in the highly competitive market as the entry of a new rival looms.
RBI says focused on bringing inflation down to 4 percent
MUMBAI The Reserve Bank of India said on Monday its focus remains on bringing down consumer inflation to 4 percent, while managing cash conditions and cleaning up the banking sector of soured assets would be its other priorities.